Neura Health isn’t just telemedicine dressed up with an app. Patients see board-certified neurologists in less than seven days. Symptom tracking plugs directly into electronic health records. Care coaching and personalized education keep patients engaged. AI-powered workflows clear the administrative sludge so doctors can focus on medicine, not paperwork. And the outcomes speak louder than any pitch deck: a 73 percent reduction in ER and urgent care visits, a 75 percent median drop in headache frequency within three months, a 67 percent cut in headache severity, and a Net Promoter Score of 90. That isn’t a pilot, it’s proof at scale.
That proof just secured Neura Health an $11.4 million Series A, pushing total funding to $22 million. The round was led by the American Heart Association’s Go Red for Women Venture Fund, their first-ever investment. Norwest Venture Partners, Koch Disruptive Technologies, Esplanade Ventures, Pear VC, Correlation Ventures, and E12 Ventures also backed the vision. This isn’t philanthropy. It’s conviction capital betting that neurology’s future runs through Neura Health.
Elizabeth Burstein isn’t simply a founder with a personal backstory. She’s a Stanford-trained product leader who built at Maven Clinic, Zocdoc, and LinkedIn before channeling her expertise into healthcare transformation. Sameer Madan is more than CTO, he’s the engineer who scaled Facebook Live, now applying that technical DNA to medicine. Their team has already cared for more than 43,000 patients nationwide while publishing peer-reviewed outcomes in Headache, Journal of Clinical Medicine, and Current Neurology and Neuroscience Reports.
The new capital accelerates their push into enterprise partnerships with payers and employers, expands condition coverage, and tackles the shortage of cognitive neurologists as America braces for the Silver Tsunami of dementia. With only one cognitive neurologist for every million patients, Neura Health isn’t filling a gap, they’re creating an entirely new lane, with a data engine that could fuel breakthroughs for pharma and beyond.
Fast Company has twice named Neura Health to its World Changing Ideas list. With momentum, clinical validation, and investor conviction, they’re showing that when data, access, and outcomes sync up, neurology doesn’t just get better, it gets Neura.
